International Menopause Society (IMS) 19th World Congress On Menopause

International Menopause Society (IMS) 19th World Congress On Menopause is organized by BT Congress and will be held from Oct 19 - 22, 2024 at Melbourne Convention and Exhibition Centre (MCEC), Melbourne, Victoria, Australia.

Topics:
General menopause

• Epidemiology, basic science and clinical research
• Diagnosis of menopause
• Symptoms of menopause including vasomotor symptoms
• Biochemical prediction of age at menopause
• Hormone and non-hormonal therapy
• Premature ovarian insufficiency
• The menopause after cancer
• Menopause and COVID-19
• Menopause in the work place

Vulvovaginal atrophy/genitourinary syndrome of menopause

• Vulvovaginal atrophy/genitourinary syndrome of menopause
• Treatment options (including vaginal estrogens and laser)
• Dermatogynecology
• Microbiota and urogenital health
• Lower urinary tract symptoms including incontinence ad recurrent UTIs
• Pelvic organ prolapse

Hormones and hormone action

• Hormones and hormone receptor signaling mechanisms
• Biological actions of sex steroids
• Selective hormone receptor modulators
• Novel treatments and regimens

Hormones and metabolism

• Obesity
• Metabolic syndrome
• Insulin resistance, diabetes and dyslipidemia
• Other topics related to hormones and the metabolism

Sexual function

• Epidemiology, basic science and clinical research
• Treatment options – psychological and medical approaches

Menopause and cardiovascular system

• Epidemiology, basic science and clinical research
• Hormones and coronary heart disease
• Hormones and thrombosis
• Hormones and cerebrovascular disease

Menopause and the brain

• Neurosteroids and actions
• Cognitive function
• Sleep and sleep disorders
• Alzheimer’s disease and other neurodegenerative disorders

Mood and mental disorders

• Epidemiology, basic science and clinical research
• Hormonal and non-hormonal treatment of mood disorders (including perimenopausal and premenstrual depression)
• Schizophrenia and other mental disorders

Musculoskeletal health

• Prevalence, epidemiology and consequences of fragility fracture
• Bone loss and osteoporosis
• Sarcopenia
• Pharmacological and non-pharmacological fracture prevention

Breast health

• Breast and breast cancer biology
• Breast cancer epidemiology
• Hormone therapy and breast cancer
• Imaging in breast cancer (screening and diagnostic)
• Breast cancer prevention (life style/pharmacotherapy)
• Tolerance and aromatase inhibitor-related side effects
• Adjuvant bisphosphonates

Gynecology

• Abnormal uterine bleeding
• Management of fibroids – medical and surgical
• Endometriosis (in perimenopause and consequences of surgery)
• PCOS – implications for menopause
• Endometrial hyperplasia and cancer
• Vulval and vaginal conditions
• Diagnostic gynecology

Other oncology

• Hormones and non-gynecological cancer
• Screening, diagnosis and treatment of women
• Treatment consequences in relation to the menopause
• Novel non hormonal treatment regimens
• Women at high genetic risk of female cancers e.g. BRCA, Lynch syndrome

Other health issues

• Autoimmune disorders
• Neurological conditions
• Sensory functions